Annotation Detail
Information
- Associated Genes
- TOP1
- Associated Variants
-
TOP1 EXPRESSION
TOP1 EXPRESSION - Associated Disease
- ovarian cancer
- Source Database
- CIViC Evidence
- Description
- Shorter progression free survival was observed in patients with low expression (IHC) of topoisomerase 1 in 16 patients with relapsed or persistent ovarian or peritoneal carcinoma after treatment with topotecan, cyclophosphamide and carboplatin followed by an autologous hematopoietic stem cell transplant.
- Variant Origin
- N/A
- Variant Origin
- N/A
- Evidence URL
- https://civic.genome.wustl.edu/links/evidence_items/910
- Gene URL
- https://civic.genome.wustl.edu/links/genes/5845
- Variant URL
- https://civic.genome.wustl.edu/links/variants/384
- Rating
- 2
- Evidence Type
- Predictive
- Disease
- Ovarian Cancer
- Evidence Direction
- Supports
- Drug
- Topotecan,Cyclophosphamide,Carboplatin
- Evidence Level
- B
- Clinical Significance
- Sensitivity/Response
- Pubmed
- 19648970
Drugs
Drug Name | Sensitivity | Supported |
---|---|---|
Carboplatin | Sensitivity | true |
Cyclophosphamide | Sensitivity | true |
Topotecan | Sensitivity | true |